RDC vs ADC: What Makes Radionuclides a Unique Therapeutic Payload? 🎯 ADC and RDC share a similar idea: use a targeting molecule to find the tumor, then let the payload do the killing. But their thera

2026-09-22

🎯 ADC and RDC share a similar idea: use a targeting molecule to find the tumor, then let the payload do the killing.

But their therapeutic payloads work very differently.

💊 ADC: Delivering a Cytotoxic Payload

An antibody-drug conjugate (ADC) typically combines an antibody with a cytotoxic drug.

After binding to a tumor-associated target, the ADC is usually internalized and releases its payload inside the cell.

Target Binding → Internalization → Payload Release → Cell Killing

Its activity therefore depends strongly on processes such as target expression, internalization and intracellular payload release.

☢️ RDC: Radiation as the Payload

A radionuclide drug conjugate (RDC) links a targeting molecule with a therapeutic radionuclide such as ¹⁷⁷Lu or ²²⁵Ac.

Once delivered to the target, the radionuclide decays and emits ionizing radiation that damages tumor cells.

Targeting → Radionuclide Decay → Radiation → Cell Damage

Unlike a chemical cytotoxic payload, the therapeutic effect comes from radioactive decay itself. This means RDCs do not necessarily depend on intracellular release of the payload.

Depending on the emitted particle and its tissue range, radiation may also affect nearby tumor cells through a cross-fire effect.

⚖️ Similar Targeting, Different Killing Mechanisms

💊 ADC: Cytotoxic Drug → Chemical Cytotoxicity ☢️ RDC: Radionuclide → Ionizing Radiation

This difference may also expand the range of targets that can be explored, including some cell-surface targets with limited internalization.

ADC and RDC are therefore better viewed as complementary approaches rather than simple alternatives.

🧬 The targeting molecule finds the target. ☢️ The radionuclide delivers the radiation.

As RDC development advances, the next challenge is finding the right match between the target, targeting molecule and therapeutic radionuclide.

#Radiopharmaceuticals #RDC #ADC #NuclearMedicine #RadionuclideTherapy #TargetedTherapy #Theranostics